Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Advanced Breast Cancer
Related studies linked through entity extraction aliases.
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Acceptability and Feasibility of PSC Model of Serious Illness Communication
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs).
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment
- Status
- RECRUITING
- Phase
- PHASE3
Emulation of the MONALEESA-2 Trial Using Specialty Oncology Electronic Health Records Databases
- Status
- COMPLETED
- Phase
- N/A
Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers
- Status
- RECRUITING
- Phase
- PHASE2
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases
- Status
- COMPLETED
- Phase
- N/A